NR4A2 and Parkinson disease: This implies that RXRα overexpression in the PD-like brain activates NURR1, which has been proposed as a standalone therapeutic target for PD [22] Consistent with a previous study demonstrating NURR1-induced TH production [17], this NURR1 upregulation was accompanied by a significant increase in TH protein.